Floor J Backes (Floor Backes)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Endometrial Cancer

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ann H Klopp, Danielle Enserro, Matthew A Powell, Marcus Randall, Julian C Schink, Robert S Mannel, Laura Holman, David Bender, Christina L Kushnir, Floor J Backes, Susan L Zweizig, Steven Waggoner, Kristin A Bradley, Lana DeSouza Lawrence, Parviz Hanjani, Christopher J Darus, William Small, Higinia R Cardenes, Jonathan M Feddock, David Scott Miller
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ann H Klopp, Danielle Enserro, Matthew A Powell, Marcus Randall, Julian C Schink, Robert S Mannel, Laura Holman, David Bender, Christina L Kushnir, Floor J Backes, Susan L Zweizig, Steven Waggoner, Kristin A Bradley, Lana DeSouza Lawrence, Parviz Hanjani, Christopher J Darus, William Small, Higinia R Cardenes, Jonathan M Feddock, David Scott Miller
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Ann H Klopp, Danielle Enserro, Matthew A Powell, Marcus Randall, Julian C Schink, Robert S Mannel, Laura Holman, David Bender, Christina L Kushnir, Floor J Backes, Susan L Zweizig, Steven Waggoner, Kristin A Bradley, Lana DeSouza Lawrence, Parviz Hanjani, Christopher J Darus, William Small, Higinia R Cardenes, Jonathan M Feddock, David Scott Miller
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Laura Moulton Chambers, Paulina Haight, Julia Chalif, Yogita Mehra, Daniel J Spakowicz, Floor J Backes, Casey M Cosgrove, David M O'Malley, Roberto Vargas, Bradley R Corr, Victoria L Bae-Jump, Rebecca C Arend
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-Oncology Research. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Laura Moulton Chambers, Paulina Haight, Julia Chalif, Yogita Mehra, Daniel J Spakowicz, Floor J Backes, Casey M Cosgrove, David M O'Malley, Roberto Vargas, Bradley R Corr, Victoria L Bae-Jump, Rebecca C Arend
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Laura Moulton Chambers, Paulina Haight, Julia Chalif, Yogita Mehra, Daniel J Spakowicz, Floor J Backes, Casey M Cosgrove, David M O'Malley, Roberto Vargas, Bradley R Corr, Victoria L Bae-Jump, Rebecca C Arend
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Mallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, Casey Ren, Zoe Barricklow, Maribelle Moufawad, Paolo Fadda, Lianbo Yu, Floor J Backes, Kari Ring, Anne Mills, Craig Slingluff, Catherine Chung, Alejandro A Gru, William E Carson
Expression of microRNAs and their target genes in melanomas originating from gynecologic sites. PloS one 18 (6) (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Mallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, Casey Ren, Zoe Barricklow, Maribelle Moufawad, Paolo Fadda, Lianbo Yu, Floor J Backes, Kari Ring, Anne Mills, Craig Slingluff, Catherine Chung, Alejandro A Gru, William E Carson
Expression of microRNAs and their target genes in melanomas originating from gynecologic sites. PloS one 18 (6) (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Mallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, Casey Ren, Zoe Barricklow, Maribelle Moufawad, Paolo Fadda, Lianbo Yu, Floor J Backes, Kari Ring, Anne Mills, Craig Slingluff, Catherine Chung, Alejandro A Gru, William E Carson
Expression of microRNAs and their target genes in melanomas originating from gynecologic sites. PloS one 18 (6) (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor J Backes, Elizabeth Swisher, Matthew Powell, Helen J Mackay
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer 130 (8) (2023)
Amanda N Fader, Dana M Roque, Eric Robb Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M O'Malley, Floor J Backes, Nicole Nevadunsky, Babak Edraki, Dirk Pikaart, William Lowery, Karim ElSahwi, Paul Celano, Stefania Bellone, Masoud Azodi, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Peter E Schwartz, Alessandro D Santin
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)
Lu Liu, Shurui Cai, Chunhua Han, Ananya Banerjee, Dayong Wu, Tiantian Cui, Guozhen Xie, Junran Zhang, Xiaoli Zhang, Eric M McLaughlin, Ming Yin, Floor J Backes, Arnab Chakravarti, Yanfang Zheng, Qi-En Wang
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2-/- Ovarian Cancer Cells. Molecular cancer therapeutics 19 (1) (2019)